By Dr. Dagna Constenla, Director of Economics & Financing at the International Vaccine Access Center at Johns Hopkins Bloomberg School of Public Health

This is the fourth post in a blog mini-series from the Dengue Vaccine Initiativeabout the collaborative work being done to ensure future access to dengue vaccines in developing nations.

Subscribe to RSS - IVAC